Kevin J. Bitterman is the founder. Founded Genocea Biosciences, Inc. in 2006 as Independent Director. Founded Visterra, Inc. in 2007 as Director. Dr. Bitterman is also the founder of Sirtris Pharmaceuticals, Inc., Remix Therapeutics, Inc. Current jobs include Chairman & Secretary at Novartis Optogenetics Research, Inc., Director at New England Venture Capital Association, Inc. since 2023, Director at ZappRx, Inc., Director at Epacing, Inc., Director at Kinaset Therapeutics, Inc., Director at Chroma Medicine, Inc., Director at Vedere Bio II, Inc., Director at Mariana Oncology, Inc., Independent Director at Disc Medicine, Inc. since 2017, President & Director at Judo Bio, Inc., Director at Resonance Medicine, Inc., Director at Nvelop Therapeutics, Inc., Partner at Atlas Venture Advisors, Inc. since 2017, Partner at Atlas Venture Life Science Advisors LLC since 2017, and Advisory Board Member at Isabella Stewart Gardner Museum since 2017.
Former jobs include Chief Executive Officer & Director at Morphic Therapeutic, Inc., Founding Chief Executive Officer at Morphic Rock LLC, Director at Biolex Therapeutics, Inc., Director at Neuronetics, Inc., Director at Solace Pharmaceuticals, Inc., Director at TARIS BioMedical LLC, Director at KALA BIO, Inc., Director at Direct Vet Marketing, Inc., Director at Navitor Pharmaceuticals, Inc., Director at Follica, Inc., Director at Editas Medicine, Inc. from 2014 to 2018, Director at InSeal Medical Ltd., Director at Morphic Holding, Inc., Director at KSQ Therapeutics, Inc., Independent Non-Executive Director at Akero Therapeutics, Inc. from 2018 to 2021, Director at Gemini Therapeutics, Inc., and Partner at Polaris Growth Management LLC from 2004 to 2017.
Education includes undergraduate degree from Rutgers State University of New Jersey in 1999 and doctorate from Harvard Medical School in 2004.
What is Kevin Bitterman's net worth?
The estimated net worth of Kevin Bitterman is at least $36.16 million as of October 17th, 2025. Bitterman owns 385,549 shares of Disc Medicine stock worth more than $36,160,641 as of December 5th. This net worth approximation does not reflect any other assets that Bitterman may own. Learn More about Kevin Bitterman's net worth.
How do I contact Kevin Bitterman?
Has Kevin Bitterman been buying or selling shares of Disc Medicine?
Over the course of the past ninety days, Kevin Bitterman has sold $14,357,512.75 in shares of Disc Medicine stock. Most recently, Kevin Bitterman sold 70,000 shares of the business's stock in a transaction on Friday, October 17th. The shares were sold at an average price of $88.91, for a transaction totalling $6,223,700.00. Following the completion of the sale, the director now directly owns 385,549 shares of the company's stock, valued at $34,279,161.59. Learn More on Kevin Bitterman's trading history.
Who are Disc Medicine's active insiders?
Disc Medicine's insider roster includes Mona Ashiya (Director), Kevin Bitterman (Director), Joanne Bryce (CFO), Jean Franchi (CFO), Rahul Khara (Insider), Brian Macdonald (Insider), John Quisel (CEO), William Savage (Insider), Pamela Stephenson (Insider), William White (Director), and Jonathan Yu (COO). Learn More on Disc Medicine's active insiders.
Are insiders buying or selling shares of Disc Medicine?
During the last year, insiders at the sold shares 36 times. They sold a total of 773,084 shares worth more than $48,364,938.08. The most recent insider tranaction occured on November, 11th when COO Jonathan Yen-Wen Yu sold 30,000 shares worth more than $2,541,000.00. Insiders at Disc Medicine own 3.6% of the company.
Learn More about insider trades at Disc Medicine. Information on this page was last updated on 11/11/2025.
